Abbott Laboratories

World Rank (Jul-30-2023)
57
Market Cap (Jul-30-2023)
196.030 Billion USD
World Rank (Dec-25-2022)
51
Market Cap (Dec-25-2022)
188.620 Billion USD
World Rank (Jan-07-2022)
43
Market Cap (Jan-07-2022)
239.710 Billion USD
World Rank (Jan-01-2021)
49
Market Cap (Jan-01-2021)
194.060 Billion USD
Company Rank in Country in 2023
Company Rank in USA in July-2023 is 34
Annual Revenue in USD
43,653 Million USD
Annual Net Income in USD
6,933 Million USD
Total Assets in USD
74,438 Million USD
Total Liabilities in USD
37,533 Million USD
Annual Results for Year ending in
Dec-2022 month
Headquarters State / City
Illinois
Headquarters Country
USA
Company Business
Healthcare
Pharmaceutical
Biotechnology
HealthCare Products
Healthcare Service
Stock Category
S&P 500
Stock Exchange
NYSE
Switzerland
Company Rank in Country in 2022
Company Rank in USA in 2022 is 29
Rank in Country (Jan-2021)
Company Rank in USA in 2021 is 32
Rank in Country (Jan-2020)
Rank in USA in 2020 is 35
Number of Employees
115,000
Employee Count as on Date
As on Dec-2022
CEO:
Robert Ford
Founders
Wallace Calvin Abbott
Yahoo
Yahoo @ NYSE
Wikipedia
Wikipedia
Facebook
Facebook
Company Website:
Abbott - Healthcare and Pharmaceutical Company
About Company Business:

Abbott Laboratories is USA based healthcare and pharmaceutical and is multi-national company. Abbott has presence in more than 150 countries. Key working areas of Abbott are related to Diabetes, Diagnostics, Neuro Modulation, Nutrition, Pharmaceuticals. They have over 113,000 employees as on 2021. Headquarters is in USA.

Facts About Company

As on 2022, Abbott Laboratories has 115,000 employees.

Abbott Laboratories annual revenue generated for period ending Dec-2022 was 43,653 million USD.

Abbott Laboratories annual net income generated for period ending Dec-2022 was 6,933 million USD.

Abbott Laboratories annual revenue generated for period ending Dec-2021 was 43,075  million USD.

Abbott Laboratories annual net income generated for period ending Dec-2021 was 7,071 million USD.

Total Assets as on Dec-2021 was 75,196 Million USD.

Founded Year
1888
Annual Results Summary:

Abbott Laboratories - Yearly Revenue and Net Profit - in Million USD:

Year - Ending Revenue Net Profit
Dec-2022 43,653 6,933
Dec-2021 43,075 7,071
Dec-2020 34,608 4,495
Dec-2019 31,904 3,687
Dec-2018 30,578 2,368
Dec-2017 27,390   477
Dec-2016 20,853 1,400

 

Balance Sheet Summary

Abbott Laboratories - Balance Sheet Summary - in Million USD:

Year Ending: Total Assets Total Liabilities Total Equity
Dec-2022 74,438 37,533 36,905
Dec-2021 75,196 39,394 35,802
Dec-2020 72,548 39,764 32,784
Dec-2019 67,887 36,799 31,088
Dec-2018 67,173 36,649 30,524
Dec-2017 76,250 45,353 30,897
Dec-2016 52,666 32,128 20,538
Quarterly Results Summary:

Abbott Laboratories - Quarterly Revenue and Net Profit - in Million USD:

Quarter - Ending Revenue Net Profit
Sep-2023 10,143 1,436
Jun-2023 9,978 1,375
Mar-2023 9,747 1,318
Dec-2022 10,091 1,033
Sep-2022 10,410 1,435
Jun-2022 11,257 2,018
Mar-2022 11,895 2,447
Dec-2021 11,468 2,378
Sep-2021 10,928 2,100
Jun-2021 10,223 1,189
Mar-2021 10,456 1,793
Dec-2020 10,701 2,162
Sep-2020 8,853 1,232
Jun-2020 7,328 537
Mar-2020 7,726 564
Dec-2019 8,314 1,049
Sep-2019 8,076 960
Jun-2019 7,979 1,006
Mar-2019 7,535 672
Dec-2018 7,765 654
Sep-2018 7,656 563
Institutional Investors

Top 30 Institutional Investors in ABBOTT LABORATORIES as on SEP-30-2022

RANK INSTITUTION NAME DATE SHARES HELD CHANGE (SHARES) CHANGE (%) VALUE (IN 1,000S)
1 VANGUARD GROUP INC 09/30/2023 15,57,65,341 28,065 0.02% $15,265,003
2 BLACKROCK INC. 09/30/2023 13,63,91,604 -7,61,941 -0.56% $13,366,377
3 CAPITAL RESEARCH GLOBAL INVESTORS 09/30/2023 7,90,60,836 18,35,578 2.38% $7,747,962
4 STATE STREET CORP 09/30/2023 7,32,33,207 -15,83,902 -2.12% $7,176,854
5 CAPITAL INTERNATIONAL INVESTORS 09/30/2023 6,28,36,937 36,58,330 6.18% $6,158,020
6 MORGAN STANLEY 09/30/2023 3,56,40,402 -7,42,792 -2.04% $3,492,759
7 GEODE CAPITAL MANAGEMENT, LLC 09/30/2023 3,24,23,419 5,44,462 1.71% $3,177,495
8 WELLINGTON MANAGEMENT GROUP LLP 09/30/2023 3,12,08,711 12,98,219 4.34% $3,058,454
9 NORTHERN TRUST CORP 09/30/2023 2,30,16,235 3,43,559 1.52% $2,255,591
10 NORGES BANK 12/31/2022 1,72,48,522 10,12,058 6.23% $1,690,355
11 JPMORGAN CHASE & CO 09/30/2023 1,67,35,021 17,60,322 11.76% $1,640,032
12 WELLS FARGO & COMPANY/MN 09/30/2023 1,65,89,120 -4,95,913 -2.90% $1,625,734
13 BANK OF AMERICA CORP /DE/ 09/30/2023 1,62,76,097 -10,29,386 -5.95% $1,595,058
14 BANK OF NEW YORK MELLON CORP 09/30/2023 1,46,03,003 -5,69,235 -3.75% $1,431,094
15 MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 09/30/2023 1,35,96,988 -45,51,738 -25.08% $1,332,505
16 STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 09/30/2023 1,35,87,118 0 0% $1,331,538
17 POLEN CAPITAL MANAGEMENT LLC 09/30/2023 1,34,80,736 -3,81,118 -2.75% $1,321,112
18 LEGAL & GENERAL GROUP PLC 09/30/2023 1,24,25,839 -4,07,288 -3.17% $1,217,732
19 CHARLES SCHWAB INVESTMENT MANAGEMENT INC 09/30/2023 1,21,53,877 32,157 0.27% $1,191,080
20 NUVEEN ASSET MANAGEMENT, LLC 09/30/2023 1,20,79,884 -5,04,217 -4.01% $1,183,829
21 ALLIANCEBERNSTEIN L.P. 09/30/2023 1,08,82,778 7,20,015 7.09% $1,066,512
22 AMERIPRISE FINANCIAL INC 09/30/2023 1,07,38,369 -12,12,030 -10.14% $1,052,360
23 FISHER ASSET MANAGEMENT, LLC 09/30/2023 96,94,131 25,119 0.26% $950,025
24 JANUS HENDERSON GROUP PLC 09/30/2023 94,38,083 -2,23,003 -2.31% $924,932
25 FLOSSBACH VON STORCH AG 09/30/2023 90,13,790 7,41,441 8.96% $883,351
26 GOLDMAN SACHS GROUP INC 09/30/2023 87,95,608 1,07,048 1.23% $861,970
27 FRANKLIN RESOURCES INC 09/30/2023 81,86,315 1,35,316 1.68% $802,259
28 AMUNDI 09/30/2023 76,09,077 8,13,944 11.98% $745,690
29 UBS ASSET MANAGEMENT AMERICAS INC 09/30/2023 73,95,681 -99,02,729 -57.25% $724,777
30 UBS GROUP AG 09/30/2023 72,35,054 40,440 0.56% $709,035

Share it on Social Media